Table 1.

Patient characteristics at baseline

N46
Dates of enrollmentJan 2011–Jan 2013
Age (median), y67 (range, 40–84)
ECOG performance status (0/1)32/14 (70%/30%)
Stage (metastatic/locally advanced)44/2 (96%/4%)
Prior chemotherapy
 Gemcitabine based34 (74%)
 FOLFIRINOX10 (22%)
 Other2 (4%)
Prior surgery14 (30%)
Prior radiation7 (15%)
Elevated baseline CA19-9 > 2× ULN34 (74%)